A recent study from the clinical research services firm indicates the pandemic continues to significantly impact clinical trial sites around the globe.
The technology from Opyl uses artificial intelligence to anticipate a COVID-19 treatment, vaccine, diagnostic or device’s chances of success in a study.
A leader from the clinical trial technology firm shares how direct data capture and other solutions can address the unique needs of such complex studies.
The company’s Medidata Detect centralized trial monitoring solution is designed to improve management of data quality, site monitoring and patient safety.
The companies will work together on solutions designed to enable sponsors to improve imaging, respiratory and cardiac safety data on decentralized trials.
A leader from the speed-focused CRO talks about the specialized needs of precision medicine trials, and how sites and sponsors can succeed on such studies.
A leader from home-based clinical services firm Illingworth Research Group talks about the evolution of mobile nursing and how it can keep trials going.
This month's spotlight on new hires, promotions and company acquisitions involves Elligo Health Research, PPD, Pfizer, Covance and other industry firms.
A leader from the specialty logistics firm discusses how the clinical researching industry is shifting, thanks in large part to the pandemic, and how to prepare for the future.
A leader with the health data specialists looks at how COVID-19 has impacted the clinical research industry, and what the future of the field might look like.
The companies will work together on putting in place technology to facilitate remote monitoring and document review for COVID-19 studies and other research.
A leader from the healthcare solutions firm shares perspective on how application of advanced technologies has driven the evolution of the entire industry.
The UK-based collaboration will include expertise across more than 40 types of cancer, with access to patients from more than 170 referring oncologists.
The two companies will work together to promote technology for at-home clinical research conducted in trials focused on developing respiratory therapies.
